Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
"SGN-CD48A multiple myeloma" - Google News
Get the latest updates from "SGN-CD48A multiple myeloma" - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated over 2 years ago
Seattle Genetics, Inc. (NASDAQ:SGEN) crossed MACD Bullish signal line on Thursday, June 18, 2020 - Stock Market Daily
almost 4 years ago
Seattle Genetics, Inc. (NASDAQ:SGEN) crossed MACD Bullish signal line on Thursday, June...
Seattle Genetics, Inc. (NASDAQ:SGEN) crossed MACD Bullish signal line on - Stock Market Daily
almost 4 years ago
Seattle Genetics, Inc. (NASDAQ:SGEN) crossed MACD Bullish signal line on Stock Market...
Seattle Genetics, Inc. - Consenus Indicates Potential 12.2% Upside - DirectorsTalk Interviews
about 4 years ago
Seattle Genetics, Inc. - Consenus Indicates Potential 12.2% Upside DirectorsTalk Interviews
Seattle Genetics - Consenus Indicates Potential 4.9% Upside - DirectorsTalk Interviews
about 4 years ago
Seattle Genetics - Consenus Indicates Potential 4.9% Upside DirectorsTalk Interviews
Seattle Genetics, Inc. - Consenus Indicates Potential 4.2% Upside - DirectorsTalk Interviews
about 4 years ago
Seattle Genetics, Inc. - Consenus Indicates Potential 4.2% Upside DirectorsTalk Interviews
Seattle Genetics, Inc. - Consenus Indicates Potential 4.2% Upside - DirectorsTalk Interviews
about 4 years ago
Seattle Genetics, Inc. - Consenus Indicates Potential 4.2% Upside DirectorsTalk Interviews
Seattle Genetics (NASDAQ:SGEN) versus Moderna (NASDAQ:MRNA) Head-To-Head Analysis - Riverton Roll
about 4 years ago
Seattle Genetics (NASDAQ:SGEN) versus Moderna (NASDAQ:MRNA) Head-To-Head Analysis Riverton Roll
Comparing Seattle Genetics (NASDAQ:SGEN) and Moderna (NASDAQ:MRNA) - Slater Sentinel
about 4 years ago
Comparing Seattle Genetics (NASDAQ:SGEN) and Moderna (NASDAQ:MRNA) Slater Sentinel
Seattle Genetics, Inc. - Consenus Indicates Potential 13.4% Upside - DirectorsTalk Interviews
about 4 years ago
Seattle Genetics, Inc. - Consenus Indicates Potential 13.4% Upside DirectorsTalk Interviews
Analyzing Moderna (NASDAQ:MRNA) & Seattle Genetics (NASDAQ:SGEN) - Riverton Roll
over 4 years ago
Analyzing Moderna (NASDAQ:MRNA) & Seattle Genetics (NASDAQ:SGEN) Riverton Roll
Seattle Genetics, Inc. - Consenus Indicates Potential 3.5% Upside - DirectorsTalk Interviews
over 4 years ago
Seattle Genetics, Inc. - Consenus Indicates Potential 3.5% Upside DirectorsTalk Interviews
Comparing Translate Bio (NASDAQ:TBIO) and Seattle Genetics (NASDAQ:SGEN) - Slater Sentinel
over 4 years ago
Comparing Translate Bio (NASDAQ:TBIO) and Seattle Genetics (NASDAQ:SGEN) Slater Sentinel